Evidence map›Paper›PMID 30359295›Full record

ArticleBMC research notes2018

Evaluating apolipoprotein E genotype status and neuroprotective effects against white matter hyperintensity development in high-altitude careers.

Richard R Chapleau, CharLee A Martin, Summer R Hughes, James C Baldwin, John Sladky, Paul M Sherman, Michael Grinkemeyer

Abstract read
In one paragraph

Article in BMC research notes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Richard R ChapleauUS Air Force School of Aerospace Medicine, Aeromedical Research Department, Applied Technology and Genomics Division, Wright-Patterson AFB, Dayton, OH, US. richard.chapleau.1@us.af.mil.
CharLee A MartinUS Air Force School of Aerospace Medicine, Aeromedical Research Department, Applied Technology and Genomics Division, Wright-Patterson AFB, Dayton, OH, US.
Summer R HughesUS Air Force School of Aerospace Medicine, Aeromedical Research Department, Applied Technology and Genomics Division, Wright-Patterson AFB, Dayton, OH, US.
James C BaldwinUS Air Force School of Aerospace Medicine, Aeromedical Research Department, Applied Technology and Genomics Division, Wright-Patterson AFB, Dayton, OH, US.
John SladkyUS Air Force School of Aerospace Medicine, Aeromedical Research Department, Operational Health and Performance Research Division, Wright-Patterson AFB, Dayton, OH, US.
Paul M ShermanUS Air Force School of Aerospace Medicine, Aeromedical Research Department, Operational Health and Performance Research Division, Wright-Patterson AFB, Dayton, OH, US.
Michael GrinkemeyerUS Air Force School of Aerospace Medicine, Aeromedical Research Department, Applied Technology and Genomics Division, Wright-Patterson AFB, Dayton, OH, US.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study considers the use of a rapid molecular assay to evaluate apolipoprotein E (ApoE) status in military subjects who have been exposed to high altitude. We hypothesize that ApoE status may be protective against developing brain white matter hyperintensities (WMHs) after high altitude exposure.

resultsWe tested 92 subjects who had been exposed to altitudes above 25,000 ft mean sea level, either as pilots or as altitude chamber technicians. We determined subject genetic status using rapid Taqman-style polymerase chain reaction genotyping and evaluated the association of ApoE subtype versus brain lesions using t-tests and two-way analyses of variance. Our results indicate that there is no significant association between ApoE genotype status and the presence of WMHs after high altitude exposure. We did observe a significantly higher number of hours spent at altitude for subjects with the ApoE E2 allele; however, the mechanism by which this may occur is not determined in this study. To more fully elucidate this effect, larger populations would be required to observe greater numbers of subjects with the E2 and E4 alleles.

Indexed as

AltitudeApolipoproteins EHumansLeukoaraiosisMaleNeuroprotectionOccupational DiseasesPilotsApolipoproteins EApolipoprotein EGenotype screeningHigh altitude acclimatizationNeuroprotection

Identifiers

PMID30359295
PMCPMC6203269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.